We're sorry, but your current browser configuration is not compatible with this site. Please enable JavaScript or switch to a JavaScript-capable browser. Learn how to enable JavaScript

Oncology

featured

Oncology

Improving Prediction of Canine Lymphoma Disease Status & Prognostication

The presence of minimal residual disease (MRD) is believed to be responsible for lymphoma relapse in dogs. Learn how newer molecular techniques may help detect MRD to better predict disease status and prognostication.

Most Popular

Oncology

Top 5 Causes of Nonblanching Skin Lesions

Peer Reviewed

Hemoabdomen in Large vs Small Dogs

Research Note: Monoclonal Antibodies for Treatment of Immunosuppressive Cancer in Dogs

Proteinuria in Canine Cancer Patients

Capsules

Oncology

Research Note: Neurectomy of a Distal Nerve Sheath Tumor

Canine B-Cell Lymphoma

Canine Mast Cell Tumors

Therapeutics Research Note: Lipid Nanoemulsions

Pug with Squamous Cell Carcinoma

Evaluating Injection-Site Sarcomas

Clinician's Brief provides relevant diagnostic and treatment information for small animal practitioners. It has been ranked the #1 most essential publication by small animal veterinarians for 9 years.*

*2007-2017 PERQ and Essential Media Studies

It's Free & Simple

Delivered to Your Inbox

Join the Conversation

Facebook

Twitter

Home

Global Edition

About Us

Employment

Capsules

Brief Media

Create Account

Oncology

Improving Prediction of Canine Lymphoma Disease Status & Prognostication

The presence of minimal residual disease (MRD) is believed to be responsible for lymphoma relapse in dogs. Learn how newer molecular techniques may help detect MRD to better predict disease status and prognostication.

Clinician's Brief provides relevant diagnostic and treatment information for small animal practitioners. It has been ranked the #1 most essential publication by small animal veterinarians for 9 years.*

Subscribe

Newsletter

Facebook

Twitter